Related Experiment Video
Updated: Jul 15, 2026

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
Culprit only versus complete coronary revascularization during primary PCI
Dahud Qarawani1, Menachem Nahir, Mouin Abboud
1Cardiovascular Department, Poria Medical Center, Israel.
Insights
Complete revascularization during primary percutaneous coronary intervention (PCI) for ST-elevation myocardial infarction (STEMI) is safe and improves clinical outcomes. This approach reduces major cardiac events and shortens hospital stays compared to treating only the culprit artery.
Area of Science:
- Cardiology
- Interventional Cardiology
- Acute Myocardial Infarction Management
Background:
- Primary percutaneous coronary intervention (PCI) is standard for ST-elevation myocardial infarction (STEMI), typically targeting only the culprit artery.
- Limited data exist on simultaneous non-culprit vessel PCI during the primary procedure.
- This study investigates the safety and efficacy of complete revascularization in STEMI patients.
Purpose of the Study:
- To evaluate the hypothesis that complete revascularization during primary PCI for STEMI is safe.
- To assess if complete revascularization improves clinical outcomes during the indexed hospitalization.
- To compare complete revascularization (CR) versus culprit-only revascularization (COR) in STEMI patients.
Main Methods:
- A prospective study of 120 consecutive STEMI patients with multivessel coronary stenosis.
- Ninety-five patients underwent complete revascularization (CR), treating both culprit and significant non-culprit lesions.
- Twenty-five patients underwent culprit-only revascularization (COR), leaving non-culprit lesions untreated during primary PCI.
Main Results:
- Complete revascularization (CR) significantly reduced major adverse cardiac events (16.7% vs. 52%, P=0.0001), including recurrent ischemia, reinfarction, acute heart failure, and in-hospital mortality.
- CR group showed lower rates of recurrent ischemia (4.2% vs. 32%), reinfarction (3.1% vs. 16%), reintervention (7.3% vs. 32%), and acute heart failure (9.4% vs. 32%).
- Hospitalization was shorter in the CR group (4.4 vs. 9.6 days, P=0.001), though transient renal dysfunction was more frequent (8.4% vs. 4%). In-hospital and one-year mortality were similar.
Conclusions:
- Multivessel PCI during acute myocardial infarction is feasible and safe.
- Complete revascularization during primary PCI for STEMI leads to an improved acute clinical course.
- These findings support a strategy of complete revascularization in STEMI patients undergoing primary PCI.
Background:
Primary percutaneous intervention (PCI) is the treatment of choice for acute ST elevation myocardial infarction. Currently it is recommended to treat only the culprit artery during the acute procedure. Only few reports describe the results of simultaneous non-culprit vessel PCI. The study hypothesizes that complete revascularization during primary PCI can be achieved safely with an improved clinical outcome during the indexed hospitalization.
Methods:
One hundred and twenty consecutive patients presented with acute ST elevation myocardial infarction (STEMI) and multivessel coronary stenosis. Ninety five underwent complete revascularization (CR): the culprit artery was opened first followed by dilatation of the other significantly narrowed arteries. Twenty five had culprit only revascularization (COR): the culprit artery only was dilated and the other arteries were left untreated during the primary PCI.
Results:
Complete revascularization (CR) was associated with reduced incidence of major cardiac events (recurrent ischemia, reinfarction, acute heart failure and in-hospital mortality 16.7 versus 52%, P=0.0001). There was a significant lower rate of recurrent ischemic episodes (4.2% versus 32%, P=0.002), myocardial reinfarction (3.1% versus 16%, P=0.01), reintervention (7.3% versus 32%, P=0.001), acute heart failure (9.4% versus 32%, P=0.01) during the indexed hospitalization and shorter hospitalization (4.4+/-1.27 versus 9.6+/-2.3, P=0.001) in the CR group. Transient renal dysfunction was more common in CR patients (8.4% versus 4% P=0.01). In-hospital and one year mortality were similar between the two groups.
Conclusion:
Multivessel PCI during acute myocardial infarction is feasible and safe. Complete revascularization resulted in an improved acute clinical course. These data support a policy of complete revascularization during primary PCI for STEMI.
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome I: Introduction
Cardiac Catheterization I: Pre-Procedure Overview
Acute Coronary Syndrome IV: Interprofessional Care
Coronary Artery Disease I: Introduction
